指南与共识儿科影像腹部MR

儿童克罗恩病临床试验中标准化磁共振成像评估肛周瘘管性疾病活动的建议

Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials.
指南 / 共识 · Inflamm Bowel Dis · 2024-01-01

该共识通过文献回顾与专家意见生成79条陈述,由15名专家组采用改良RAND/UCLA适宜性方法评分,认为改良Van Assche指数(mVAI)和MAGNIFI-CD适用于儿童肛周瘘管性克罗恩病临床试验,临床可见瘘管及骨盆MRI至少1个瘘管或脓肿可作为试验纳入标准,共同主要临床和影像终点及患者报告结局也被认为适宜。

要点

  • mVAI和MAGNIFI-CD被认为适用于儿童肛周瘘管性克罗恩病临床试验的影像评估。
  • 临床可见瘘管和骨盆MRI至少1个瘘管或脓肿被认为可作为试验纳入标准。
  • 共同主要临床和影像终点及患者报告结局被认为适宜。

核心结论

  • 儿童肛周瘘管性疾病的治疗结局必须包括MRI,现有多项评估工具(特别是mVAI和MAGNIFI-CD)可改编用于儿童,评估这些指数在儿童人群中使用时操作特性的进一步研究正在进行中。

研究设计与样本

  • 通过文献回顾和专家意见生成79条与儿童肛周瘘管性克罗恩病活动MRI评估及临床试验设计相关的陈述,由15名胃肠病学家、放射科医生和外科医生组成的小组采用改良RAND/加州大学洛杉矶分校适宜性方法对陈述适宜性进行评分。

诊断标准与关键数值

  • mVAI和MAGNIFI-CD被认为适用于儿童肛周瘘管性疾病临床试验的评估工具。
  • 临床可见瘘管和影像学疾病(定义为骨盆MRI上至少1个瘘管或脓肿)被认为可作为试验纳入标准。

临床应用与阅片要点

  • 儿童肛周瘘管性疾病的治疗结局必须包括MRI。
  • 现有多项评估工具(特别是mVAI和MAGNIFI-CD)可改编用于儿童。

局限性

  • 评估这些指数在儿童患者人群中使用时操作特性的进一步研究正在进行中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Perianal fistulas and abscesses occur commonly as complications of pediatric Crohn's disease (CD). A validated imaging assessment tool for quantification of perianal disease severity and activity is needed to evaluate treatment response. We aimed to identify magnetic resonance imaging (MRI)-based measures of perianal fistulizing disease activity and study design features appropriate for pediatric patients.

METHODS: Seventy-nine statements relevant to MRI-based assessment of pediatric perianal fistulizing CD activity and clinical trial design were generated from literature review and expert opinion. Statement appropriateness was rated by a panel (N = 15) of gastroenterologists, radiologists, and surgeons using modified RAND/University of California Los Angeles appropriateness methodology.

RESULTS: The modified Van Assche Index (mVAI) and the Magnetic Resonance Novel Index for Fistula Imaging in CD (MAGNIFI-CD) were considered appropriate instruments for use in pediatric perianal fistulizing disease clinical trials. Although there was concern regarding the use of intravascular contrast material in pediatric patients, its use in clinical trials was considered appropriate. A clinically evident fistula tract and radiologic disease defined as at least 1 fistula or abscess on pelvic MRI were considered appropriate trial inclusion criteria. A coprimary clinical and radiologic end point and inclusion of a patient-reported outcome were also considered appropriate.

CONCLUSION: Outcomes of treatment of perianal fistulizing disease in children must include MRI. Existing multi-item measures, specifically the mVAI and MAGNIFI-CD, can be adapted and used for children. Further research to assess the operating properties of the indices when used in a pediatric patient population is ongoing.

来源:Inflamm Bowel Dis,查看原文。版权归原作者所有。

引用

  1. Crowley E, Ma C, Guizzetti L, et al. Recommendations for Standardizing MRI-based Evaluation of Perianal Fistulizing Disease Activity in Pediatric Crohn's Disease Clinical Trials. Inflamm Bowel Dis. 2024. PMID: 37524088. doi:10.1093/ibd/izad134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。